Stay updated on FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.

Latest updates to the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a new build of the page. This appears to be a small maintenance update rather than a substantive content change.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s site/release revision indicator was updated from v3.5.2 to v3.5.3, reflecting a technical site update rather than any modification to the study details.SummaryDifference0.0%

- Check37 days agoChange DetectedA new revision v3.5.2 has been added, replacing the previous revision v3.5.0.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded a publication citation for Olutasidenib in IDH1-mutated chondrosarcoma (Nat Commun 2026, 17(1):2224). Removed the Online ahead of print version.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded Hepatocellular carcinoma as a related topic and updated the page revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 in the page footer.SummaryDifference0.0%

Stay in the know with updates to FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.